Page 4 - நைட் சிகிச்சை இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நைட் சிகிச்சை இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நைட் சிகிச்சை இன்க் Today - Breaking & Trending Today

Knight Therapeutics Inc. announces voting results from the Annual Meeting

32.60%
The results of the final votes regarding all matters subject to a vote during the Meeting will also be made available on SEDAR (www.sedar.com).
About Knight Therapeutics Inc.
Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing and commercializing innovative pharmaceutical products for Canada and Latin America. Knight owns Biotoscana Investments S.A., a pan-Latin American specialty pharmaceutical company. Knight Therapeutics Inc. s shares trade on TSX under the symbol GUD. For more information about Knight Therapeutics Inc., please visit the company s web site at www.gud-knight.com or www.sedar.com. ....

United States , Robertn Lande , Michaelj Tremblay , Samira Sakhia , Jonathan Ross Goodman , Janice Murray , Knight Therapeutics Inc , Ernst Young , Annual Meeting , Management Information Circular , Omnibus Equity Incentive Plan , Therapeutics Inc , Latin American , Knight Therapeutics , Annual Report , Annual Information Form , ஒன்றுபட்டது மாநிலங்களில் , சமிரா சாக்கிய , ஜொனாதன் ரோஸ் நல்ல மனிதன் , ஜானிஸ் முர்ரே , நைட் சிகிச்சை இன்க் , எர்னிஸ்ட இளம் , ஆண்டு சந்தித்தல் , மேலாண்மை தகவல் வட்ட , சர்வபுலம் பங்கு ஊக்கத்தொகை திட்டம் , சிகிச்சை இன்க் ,

Knight Therapeutics Reports First Quarter 2021 Results

Knight Therapeutics Reports First Quarter 2021 Results
Knight Therapeutics Inc. a leading pan-American specialty pharmaceutical company, today reported financial results for its first quarter ended March 31, 2021. All currency amounts are in thousands except for share and per share amounts. All currencies are Canadian unless otherwise specified. Q1 2021 Highlights Financials Revenues were $46,069, an increase of $230 or 1% over prior year. Gross margin generated of …
Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its first quarter ended March 31, 2021. All currency amounts are in thousands except for share and per share amounts. All currencies are Canadian unless otherwise specified. ....

United States , Robertn Lande , Michaelj Tremblay , Samira Sakhia , Arvind Utchanah , Jonathan Ross Goodman , Janice Murray , Jonathan Goodman , Company Argentine , Toronto Stock Exchange , Knight Therapeutics Inc , Health Canada , Shareholders Of The Company , Atea Pharmaceutics Inc , Knight Therapeutics , Kamal Khouri , Chief Business , Normal Course Issuer Bid , Irritable Bowel Syndrome , Executive Chairman , Latin America , Chief Operating Officer , Sectoral Asset Management , Toll Free , Therapeutics Inc , Latin American ,

Knight Therapeutics Announces Leadership Change

Knight Therapeutics Announces Leadership Change
May 13, 2021 09:23 ET
| Source:
Knight Therapeutics
Knight Therapeutics
- GUD to Great -
MONTREAL, May 13, 2021 (GLOBE NEWSWIRE) Knight Therapeutics Inc. (TSX: GUD) ( Knight ) is pleased to announce that Samira Sakhia will assume the role of President and Chief Executive Officer, Knight Therapeutics Inc., effective September 1, 2021. Ms. Sakhia currently serves as Knight’s President and Chief Operating Officer.
Jonathan Ross Goodman will assume the role of Executive Chairman and will help direct Knight’s strategy through his role as Executive Chairman of the Board and by providing the full benefit of his 27 years of experience, leadership and guidance. At 17.2% ownership, Jonathan remains Knight’s largest shareholder. ....

United States , Samira Sakhia , Jonathan Ross Goodman , Knight Therapeutics Inc , Chief Executive Officer , Chief Operating , Ross Goodman , Executive Chairman , James Gale , Jonathan Ross , Latin America , Lead Director , James Gales , Managing Partner , Signet Healthcare , Therapeutics Inc , Latin American , Toronto Stock Exchange Gud , Knight Therapeutics , ஒன்றுபட்டது மாநிலங்களில் , சமிரா சாக்கிய , ஜொனாதன் ரோஸ் நல்ல மனிதன் , நைட் சிகிச்சை இன்க் , தலைமை நிர்வாகி அதிகாரி , தலைமை இயங்குகிறது , ரோஸ் நல்ல மனிதன் ,

Knight to Present at the 2021 RBC Capital Markets Global Healthcare Conference

Knight to Present at the 2021 RBC Capital Markets Global Healthcare Conference
Knight Therapeutics Inc. a leading pan-American specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Operating Officer, is scheduled to participate in a fireside chat at the 2021 RBC Capital Markets Global Healthcare Conference on Tuesday, May 18, 2021 at 8:35 am ET. A live webcast of the event will be available at the following link: Event . A copy of the presentation will be …
Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Operating Officer, is scheduled to participate in a fireside chat at the 2021 RBC Capital Markets Global Healthcare Conference on Tuesday, May 18, 2021 at 8:35 am ET. A live webcast of the event will be available at the following link: Event . A copy of the presentation will be available at www.gud-knight.com . ....

United States , Samira Sakhia , Arvind Utchanah , Knight Therapeutics Inc , Knight Therapeutics , Chief Operating Officer , Markets Global Healthcare Conference , Therapeutics Inc , Latin American , Annual Report , Annual Information Form , ஒன்றுபட்டது மாநிலங்களில் , சமிரா சாக்கிய , நைட் சிகிச்சை இன்க் , நைட் சிகிச்சை , தலைமை இயங்குகிறது அதிகாரி , சந்தைகள் உலகளாவிய சுகாதாரம் மாநாடு , சிகிச்சை இன்க் , லத்தீன் அமெரிக்கன் , ஆண்டு அறிக்கை , ஆண்டு தகவல் வடிவம் ,

Baystreet.ca - U.S. CPI in Focus Next Week

U.S. CPI in Focus Next Week
U.S. CPI in Focus Next Week
Monday
Duke Energy (NYSE: DUK) (Q4) EPS projected for $1.24, compared to $1.14 the prior-year quarter.
Marriott International, Inc. (NASDAQ: MAR) (Q1) EPS projected for three cents, compared to 26 cents the prior-year quarter.
BioNTech SE (NASDAQ: BNTX) (Q1) EPS projected for $3.44, compared to a loss of 26 cents inthe prior-year quarter.
Featured Earnings
5N Plus Inc. (T.VNP) (Q1) EPS projected of four cents, identical to the prior-year quarter.
Finning International Inc. (T.FTT) (Q1) EPS projected for 36 cents, compared to 38 cents in the prior-year quarter.
Sleep Country Canada Holdings Inc. (T.ZZZ) (Q1) EPS projected for 21 cents, compared to 74 cents in the prior-year quarter. ....

Country Canada Holdings Inc , Monthly Survey Of Manufacturing March , Life Healthcare Inc , Steppe Gold Ltd , Wendy Company , Emera Incorporated , Materials Inc , Marriott International Inc , Centerra Gold Inc , Electronic Arts Inc , Alibaba Inc , Knight Therapeutics Inc , Aimia Inc , Walt Disney Co , Canadian Tire Corporation Limited , K Bro Linen Inc , Group Inc , George Weston Limited , International Inc , Lumentum Holdings Inc , Dye Durham Limited , N Plus Inc , Aritzia Inc , Duke Energy , Endeavour Mining Corporation , Nexgen Energy Ltd ,